The ACLU, breast cancer patients, and researchers are taking the holder of the patent on the breast cancer gene to court. Myriad Genetics holds the patent to the BRCA1 and BRCA2 gene mutations that cause hereditary breast and ovarian cancer.
You can read the suit here. For media coverage, there is a good article found here.
This would be a landmark ruling if the suit is successful. Though even if it is, there's nothing stopping companies from patenting the process used to test for their novel findings...
You can read the suit here. For media coverage, there is a good article found here.
This would be a landmark ruling if the suit is successful. Though even if it is, there's nothing stopping companies from patenting the process used to test for their novel findings...
